The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT00620022
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG:
Indacaterol 300 μg
DRUG:
Placebo
Sponsor
Novartis